Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07195708) titled 'Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Boston Scientific Corporation
Condition:
Weight Loss
Intervention:
Device: Treatment group
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 30, 2026
Target Sample Size: 144
To know more, visit https://clinicaltrials.gov/study/NCT07195708
Published by HT Digital Content Services with permission from Health Daily Dige...